|
Glomerulonephritis
|
0.200 |
Therapeutic
|
disease |
RGD |
Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model.
|
1668710 |
1991 |
|
Shock, Traumatic
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
|
2165204 |
1990 |
|
Endotoxemia
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Platelet activating factor receptor antagonist improves survival and attenuates eicosanoid release in severe endotoxemia.
|
2178565 |
1990 |
|
Acute kidney injury
|
0.200 |
Therapeutic
|
disease |
RGD |
Role of platelet activating factor in endotoxemic acute renal failure in the male rat.
|
2538527 |
1989 |
|
Hypotension
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
|
3011900 |
1986 |
|
Neutropenia
|
0.200 |
Therapeutic
|
disease |
RGD |
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.
|
3011900 |
1986 |
|
Transient Ischemic Attack
|
0.200 |
Therapeutic
|
disease |
RGD |
Effect of the platelet-activating factor antagonist BN 50739 and its diluents on mitochondrial respiration and membrane lipids during and following cerebral ischemia.
|
8158141 |
1994 |
|
Allergic asthma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Using two-color immunofluorescence techniques and highly purified cell populations, it was not possible to detect surface PAFR protein or functional PAFR on resting and in vivo or in vitro activated T and B cells derived from nonallergic individuals or patients with allergic asthma.
|
8207248 |
1994 |
|
Other specified forms of pleural effusion, except tuberculous
|
0.200 |
Therapeutic
|
disease |
RGD |
Interference of the PAF receptor antagonist, PCA 4248, with the rat pleurisy evoked by inflammatory mediators or allergen.
|
8395390 |
1993 |
|
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
An elongated splice variant was identified in the 5'-untranslated region of the tissue-type PAF-R transcript (334 bp) in colonic epithelial crypts and tumors.
|
9603913 |
1998 |
|
Multiple Organ Failure
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Protective effects of a PAF receptor antagonist and a neutrophil elastase inhibitor on multiple organ failure induced by cerulein plus lipopolysaccharide in rats.
|
9750012 |
1998 |
|
Neutrophilia (disorder)
|
0.210 |
Therapeutic
|
disease |
RGD |
Scorpion venom-induced neutrophilia is inhibited by a PAF receptor antagonist in the rat.
|
10770284 |
2000 |
|
Neutrophilia (finding)
|
0.200 |
Therapeutic
|
phenotype |
RGD |
Scorpion venom-induced neutrophilia is inhibited by a PAF receptor antagonist in the rat.
|
10770284 |
2000 |
|
Arteriosclerosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis.
|
11085958 |
2000 |
|
Atherosclerosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Expression of platelet-activating factor receptor in human carotid atherosclerotic plaques: relevance to progression of atherosclerosis.
|
11085958 |
2000 |
|
Reperfusion Injury
|
0.200 |
Therapeutic
|
disease |
RGD |
Effects of the PAF receptor antagonist UK74505 on local and remote reperfusion injuries following ischaemia of the superior mesenteric artery in the rat.
|
11139461 |
2000 |
|
Liver Failure, Acute
|
0.200 |
Biomarker
|
disease |
RGD |
Role of PAF in acute liver injury after extended hepatectomy: overexpression of PAF receptor mRNA in Kupffer cells.
|
11414308 |
2001 |
|
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Platelet-activating factor receptor (PAF-R) transcripts were analysed by reverse transcriptase-polymerase chain reaction in five human cancer cell lines derived from the breast (BT20, SKBR3 and T47D cells), the pancreas (Miapaca cells) and the bladder (5,637 cells) in order to confirm the existence of a splice variant of the PAF-R transcript 2.
|
12467527 |
2002 |
|
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
Platelet-activating factor receptor (PAF-R) transcripts were analysed by reverse transcriptase-polymerase chain reaction in five human cancer cell lines derived from the breast (BT20, SKBR3 and T47D cells), the pancreas (Miapaca cells) and the bladder (5,637 cells) in order to confirm the existence of a splice variant of the PAF-R transcript 2.
|
12467527 |
2002 |
|
Conjunctivitis
|
0.200 |
Biomarker
|
disease |
RGD |
Direct action of platelet activating factor (PAF) induces eosinophil accumulation and enhances expression of PAF receptors in conjunctivitis.
|
15735601 |
2005 |
|
Multiple Sclerosis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.
|
15748960 |
2005 |
|
Multiple Sclerosis
|
0.010 |
GeneticVariation
|
disease |
LHGDN |
These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.
|
15748960 |
2005 |
|
Arteriosclerosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis.
|
16386258 |
2006 |
|
Atherosclerosis
|
0.020 |
Biomarker
|
disease |
BEFREE |
Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis.
|
16386258 |
2006 |
|
Lissencephaly
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, logistic regression showed that poor Wisconsin Card Sorting Test-Perseverative Errors performance was the only predictor of belonging to the positive lissencephaly critical region/platelet-activating-factor receptor group.
|
16549273 |
2006 |